AXSM

NASDAQ HEALTHCARE

Axsome Therapeutics Inc

$177.08

-$2.17 (-1.21%)

Live quote

52w: $117.30 – $260.19

Loading chart…

P/E Ratio—

P/B Ratio112.71

EV/EBITDA—

Debt/Equity—

ROE-219.89%

ROIC—

Revenue Growth65.55%

Gross Margin—

Axsome Therapeutics, Inc., a biopharmaceutical company, is dedicated to developing new therapies for central nervous system (CNS) disorders in the United States. The company is headquartered in New York, New York.

Own AXSM? Track it here.

Create a free account to add AXSM to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account